Bhagyanagar India Limited confirmed that Surendra Bhutoria ceased to be the Chief Financial Officer (CFO) effective October 7, 2026. The departure resulted from the transfer of his employment to Tieramet Limited, a related entity within the group structure.

The company disclosed this development to stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing clarifies that the cessation was not due to resignation or removal, but specifically consequent upon the internal employment transfer.

Cessation details

The company stated that it will appoint a new Chief Financial Officer in due course. Requisite disclosures regarding the appointment will be made to the stock exchanges in accordance with applicable SEBI LODR provisions. The detailed information was submitted in Annexure-I of the regulatory filing.

Governance context

The disclosure highlights that no resignation letter with detailed reasons was required, as the change was administrative in nature. The Managing Director, Devendra Surana, signed off on the intimation. The company maintains its registered office in Hyderabad, Telangana.

What the numbers show

The transition reflects an internal reallocation of key management personnel within the Surana Group ecosystem rather than an external exit. By moving the CFO role to Tieramet Limited, Bhagyanagar India Limited signals a consolidation of financial leadership across its associated entities, pending the formal appointment of a successor for the listed entity.

Bhagyanagar India Limited disclosed the voting results and scrutinizer's report for its 41st Annual General Meeting (AGM), held on September 30, 2026, via video conferencing. The company confirmed that all seven resolutions proposed in the notice dated August 27, 2026, were passed with the requisite majority.

The meeting addressed key corporate governance matters, including the adoption of audited financial statements for FY26 and the re-appointment of Devendra Surana as Managing Director. Voting was conducted through remote e-voting prior to the meeting and electronic voting during the session, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resolution outcomes

The shareholders approved the adoption of both standalone and consolidated financial statements for the financial year ended March 31, 2026. This ordinary resolution received overwhelming support, with 99.99% of valid votes cast in favor. Similarly, the re-appointment of Venkateswara Rao Nukala as a director retiring by rotation was approved with an identical margin of support.

A special resolution to re-appoint Devendra Surana as Managing Director also passed successfully. While promoter group votes constituted a significant portion of the total shareholding, their participation did not alter the outcome for this specific resolution, which secured 99.90% in favor among valid votes polled.

Scrutiny of related party transactions

Notable scrutiny occurred regarding resolutions involving related party transactions. For Item No. 5 (Section 185 transactions) and Item No. 6 (Section 186 loans/investments), the promoter group's votes were treated as invalid due to material interest conflicts. Consequently, the final results for these special resolutions were determined solely by public shareholder votes.

In these cases, public institutional investors voted 60.33% against the resolutions, while public non-institutional investors voted 99.74% in favor. Despite the split among institutions, the combined valid public votes resulted in an 88.19% approval rate for both items. Item No. 7, concerning material related party transactions with Tieramet Limited, saw similar treatment of promoter votes, resulting in a 99.79% approval from valid public votes.

What the numbers show

The voting data reveals a distinct divergence in sentiment between institutional and retail public shareholders on governance-related matters. While non-institutional public shareholders consistently voted nearly unanimously in favor across all seven items, institutional investors showed significant dissent on specific statutory approvals. Specifically, institutions opposed Section 185 and Section 186 transactions by a margin of 60.33%, contrasting sharply with their unanimous support for routine matters like financial statement adoption. This pattern suggests that institutional investors are applying stricter scrutiny to capital allocation and related-party lending mechanisms compared to routine operational approvals.